Similar articles for PMID: 25868746

Year	Number of Results
1968	1
2000	1
2001	1
2004	4
2005	5
2006	7
2007	15
2008	11
2009	10
2010	11
2011	9
2012	6
2013	11
2014	9
2015	10
2016	5
2017	4
2018	6
2019	5
2020	4
2021	1
2022	4
2024	0

1

Discovery of novel spiro 1,3,4-thiadiazolines as potent, orally bioavailable and brain penetrant KSP inhibitors.

Mansoor UF, Angeles AR, Dai C, Yang L, Vitharana D, Basso AD, Gray K, Tang H, Liu M, Liang L, Allbritton O, Siddiqui MA. Mansoor UF, et al. Bioorg Med Chem. 2015 May 15;23(10):2424-34. doi: 10.1016/j.bmc.2015.03.052. Epub 2015 Mar 27. Bioorg Med Chem. 2015. PMID: 25868746

2

SCH 2047069, a novel oral kinesin spindle protein inhibitor, shows single-agent antitumor activity and enhances the efficacy of chemotherapeutics.

Basso AD, Liu M, Dai C, Gray K, Nale L, Tevar S, Lee S, Liang L, Ponery A, Yaremko B, Smith E, Tang H, Sheth PR, Siddiqui MA, Hicklin DJ, Kirschmeier P. Basso AD, et al. Mol Cancer Ther. 2010 Nov;9(11):2993-3002. doi: 10.1158/1535-7163.MCT-10-0548. Epub 2010 Oct 26. Mol Cancer Ther. 2010. PMID: 20978164

3

Discovery of allosteric inhibitors of kinesin spindle protein (KSP) for the treatment of taxane-refractory cancer: MK-0731 and analogs.

Cox CD, Garbaccio RM. Cox CD, et al. Anticancer Agents Med Chem. 2010 Nov 1;10(9):697-712. doi: 10.2174/187152010794479807. Anticancer Agents Med Chem. 2010. PMID: 21235439 Review.

4

Novel ATP-competitive kinesin spindle protein inhibitors.

Parrish CA, Adams ND, Auger KR, Burgess JL, Carson JD, Chaudhari AM, Copeland RA, Diamond MA, Donatelli CA, Duffy KJ, Faucette LF, Finer JT, Huffman WF, Hugger ED, Jackson JR, Knight SD, Luo L, Moore ML, Newlander KA, Ridgers LH, Sakowicz R, Shaw AN, Sung CM, Sutton D, Wood KW, Zhang SY, Zimmerman MN, Dhanak D. Parrish CA, et al. J Med Chem. 2007 Oct 4;50(20):4939-52. doi: 10.1021/jm070435y. Epub 2007 Aug 29. J Med Chem. 2007. PMID: 17725339

5

Antitumor activity of a kinesin inhibitor.

Sakowicz R, Finer JT, Beraud C, Crompton A, Lewis E, Fritsch A, Lee Y, Mak J, Moody R, Turincio R, Chabala JC, Gonzales P, Roth S, Weitman S, Wood KW. Sakowicz R, et al. Cancer Res. 2004 May 1;64(9):3276-80. doi: 10.1158/0008-5472.can-03-3839. Cancer Res. 2004. PMID: 15126370

6

Discovery of tetrahydro-beta-carbolines as inhibitors of the mitotic kinesin KSP.

Liu F, Yu LQ, Jiang C, Yang L, Wu WT, You QD. Liu F, et al. Bioorg Med Chem. 2010 Jun 15;18(12):4167-77. doi: 10.1016/j.bmc.2010.05.024. Epub 2010 May 11. Bioorg Med Chem. 2010. PMID: 20537544

7

Mechanism of inhibition of human KSP by monastrol: insights from kinetic analysis and the effect of ionic strength on KSP inhibition.

Luo L, Carson JD, Dhanak D, Jackson JR, Huang PS, Lee Y, Sakowicz R, Copeland RA. Luo L, et al. Biochemistry. 2004 Dec 7;43(48):15258-66. doi: 10.1021/bi048282t. Biochemistry. 2004. PMID: 15568818

8

Developments of kinesin spindle protein inhibitors as antitumor agents based on the five-membered heterocycle scaffolds.

Zhao GD, Wan RZ, Liu ZP. Zhao GD, et al. Curr Med Chem. 2014;21(23):2691-701. doi: 10.2174/0929867321666140304110609. Curr Med Chem. 2014. PMID: 24606497 Review.

9

Progress on kinesin spindle protein inhibitors as anti-cancer agents.

Zhang Y, Xu W. Zhang Y, et al. Anticancer Agents Med Chem. 2008 Aug;8(6):698-704. Anticancer Agents Med Chem. 2008. PMID: 18690830 Review.

10

Role of KSP Inhibitors as Anti-cancer Therapeutics: An Update.

Chamariya R, Suvarna V. Chamariya R, et al. Anticancer Agents Med Chem. 2022;22(14):2517-2538. doi: 10.2174/1871520622666220119093105. Anticancer Agents Med Chem. 2022. PMID: 35043768 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

123 results

Results by year